Cardiac Rhythm Management Devices Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Cardiac Rhythm Management Devices Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Summary
GlobalData's Medical Devices sector report, “Cardiac Rhythm Management Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Cardiac Rhythm Management Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Cardiac Rhythm Management (CRM) devices are those devices which are used to restore the natural synchronized pumping rhythm of the heart.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Cardiac Rhythm Management Devices under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Cardiac Rhythm Management Devices and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Cardiac Rhythm Management Devices under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
About GlobalData
Introduction
Cardiac Rhythm Management Devices Overview
Products under Development
Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development
Table Figure 1: Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development
Table Cardiac Rhythm Management Devices - Pipeline Products by Stage of Development
Cardiac Rhythm Management Devices - Pipeline Products by Segment
Table Barostim neo - Heart Failure - Barostim Therapy in Heart Failure with Reduced Ejection Fraction: A Post-market Registry with the CE-marked Barostim Neo System
DHS Medical Company Overview
DHS Medical Pipeline Products & Ongoing Clinical Trials Overview
Table DHS Medical Pipeline Products & Ongoing Clinical Trials Overview
Table Drimmer - Product Status
Table Drimmer - Product Description
Table Twistek - Product Status
Table Twistek - Product Description
Drexel University Company Overview
Drexel University Pipeline Products & Ongoing Clinical Trials Overview
Table Drexel University Pipeline Products & Ongoing Clinical Trials Overview
Table Conductance Controller Implant - Product Status
Table Second Generation WiSE CRT System - Product Status
Table Second Generation WiSE CRT System - Product Description
Table WiSE CRT System - Product Status
Table WiSE CRT System - Product Description
Table EBR Systems Inc - Ongoing Clinical Trials Overview
Table WiSE CRT System - A Feasibility Study Into the Implant of the WiSE CRT System with an Intracardiac Pacemaker to Achieve Totally Leadless CRT
Table WiSE CRT System - Achieving Conduction System Activation with Leadless Left Ventricular Endocardial Pacing
Table WiSE CRT System - Stimulation Of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in Non-Responders, Previously Untreatable and High Risk Upgrade Patients (SOLVE CRT)
Mar 30, 2023: Integer Schedules First Quarter 2023 Earnings Release and Conference Call for April 27, 2023
Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
Mar 13, 2023: T2 Biosystems Announces Fourth Quarter and Full Year 2022 Financial Results
Feb 21, 2023: Orthofix Medical Schedules Fourth Quarter Earnings Release and Conference Call for March 6, 2023
Feb 16, 2023: Integer Holdings Reports Results for Fourth Quarter and Full Year 2022
Feb 09, 2023: iRhythm Technologies to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
Feb 08, 2023: Nihon Kohden Announces Consolidated Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2023
Feb 07, 2023: JMS Co Announces Financial Results for the 3rd Quarter of FYE March 2023
Feb 06, 2023: Surmodics Lays off 58 employees
Feb 06, 2023: Surmodics Reports First Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance
Feb 01, 2023: Japan Lifeline Announces Consolidated Financial Results for the Nine months Ended December 31, 2022
Jan 31, 2023: Fukuda Denshi Announces Summary of Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2023
Jan 31, 2023: Surmodics to Host Virtual Annual Meeting of Shareholders
Jan 30, 2023: Medtronic appoints Michael Blackwell as India vice-president
Jan 30, 2023: Philips to lay off 6,000 employees in drive to improve profitability
Jan 23, 2023: T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2022 Financial Results
Jan 12, 2023: CVRx to Report Fourth Quarter and Fiscal Year 2022 Financial and Operating Results and Host Conference Call on January 26, 2023
Jan 09, 2023: Orthofix Medical Announces Preliminary SeaSpine and Orthofix 2022 Fourth Quarter and Full-Year Net Sales Results
Jan 09, 2023: iRhythm Technologies Shares Preliminary Fourth Quarter 2022 Highlights and Business Update at the 41st Annual J.P. Morgan Healthcare Conference
Jan 09, 2023: CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2022 Financial Results
Jan 02, 2023: Ventripoint Diagnostics Announces Dr. Alvira Macanovic as President and CEO
Dec 20, 2022: CVRx Appoints Industry Veteran Kevin Hykes to Board of Directors
Nov 25, 2022: Concord Medical Schedules 2022 Annual Meeting of Shareholders
Nov 23, 2022: Medtronic Reports Quarterly Earnings
Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
Nov 22, 2022: Mayo Clinic surgeon takes the wheel as Kwik Trip's new CEO
Nov 17, 2022: Mindray North America unveils new true to life vital signs monitor
Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday
Nov 09, 2022: Nihon Kohden Consolidated Financial Results for the 2nd Quarter of the Fiscal Year Ending March 31, 2023
Nov 04, 2022: JMS Co. Announces Consolidated Financial Highlights for the Interim Period Ended September 2022
Oct 31, 2022: Fukuda Denshi Financial Results for the Second Quarter of the Fiscal Year Ending March 2023
Oct 31, 2022: Fukuda Denshi Notice of the Revision Forecast of the Financial Results, Distribution of Surplus and Year-end Dividend Forecast, Stock Split
Oct 27, 2022: Integer Holdings Reports Third Quarter 2022 Results
Oct 25, 2022: Orthofix Medical Schedules Third Quarter Earnings Release and Conference Call for November 3, 2022
Oct 24, 2022: Philips To Cut 4000 Jobs As Company Faces Multiple Challenges
Oct 19, 2022: Nihon Kohden Announces a Revision to its Forecast for Financial Results
Oct 12, 2022: Philips provides update on its financial performance in Q3 2022
Oct 12, 2022: T2 Biosystems Announces Preliminary Third Quarter 2022 Financial Results and Updates 2022 Financial Outlook
Oct 11, 2022: Orthofix Announces Preliminary Third Quarter and Year-To-Date 2022 Net Sales Results
Sep 30, 2022: Natalie Caine named chief administrative officer at Mayo Clinic in Rochester
Sep 23, 2022: Concord Medical Reports Financial Results for the First Half of 2022
Sep 14, 2022: Orthofix Medical Announces Participation in Upcoming Sidoti Virtual Investor Conference
Sep 07, 2022: Medtronic to appear at September investor conferences
Aug 31, 2022: iRhythm Technologies to Host Analyst & Investor Day on September 21, 2022
Aug 23, 2022: Surmodics to Present at Upcoming Gilmartin Emerging Growth Company Showcase Wednesday, August 31, 2022
Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results
Aug 23, 2022: Medtronic Announces Quarterly Earnings Results
Aug 18, 2022: Philips to convene Extraordinary General Meeting of Shareholders to appoint Roy Jakobs as new President and Chief Executive Officer
Aug 16, 2022: Boston Scientific Announces Upcoming Conference Schedule
Aug 08, 2022: ClearPoint Neuro Announces Appointment of Mary McNamara-Cullinane as Vice President of Regulatory Affairs
Aug 05, 2022: JMS Co. Announces Consolidated Financial Highlights for the Interim Period Ended June 2022
Jul 29, 2022: CVRx to Present at the Canaccord Genuity 42nd Annual Growth Conference
Jul 28, 2022: Integer Holdings Reports Second Quarter 2022 Results
Jul 25, 2022: iRhythm Technologies Announces the Addition of Two Executive Leaders to Advance Strategic Growth and Operational Excellence
Jun 28, 2022: Japan Lifeline Co. Notice of Resolution of the 42nd Annual General Meeting of Shareholders
Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director
Jun 07, 2022: Ventripoint exhibiting at the American Society of Echocardiography 33rd Annual Scientific Session
May 31, 2022: CONMED Announces Private Offering of $600 Million of Convertible Senior Notes
May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results
May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase
May 16, 2022: Orthofix Medical Announces Participation in Upcoming UBS Global Healthcare Conference
May 13, 2022: Nihon Kohden Consolidated Financial Results for the Fiscal Year Ended March 31, 2022
May 13, 2022: Nihon Kohden announces FY2021 consolidated financial results
May 10, 2022: Stereotaxis Reports 2022 First Quarter Financial Results
May 09, 2022: BaroPace Adds Michael Coyle to Board
May 05, 2022: iRhythm Technologies Announces First Quarter 2022 Financial Results
May 04, 2022: Conmed Announces First Quarter 2022 Financial Results
Apr 29, 2022: Concord Medical Files 2021 Annual Report on Form 20-F
Apr 28, 2022: Boston Scientific reports net sales of $3.03bn in Q1 2022
Apr 28, 2022: Orthofix Medical Schedules First Quarter Earnings Release and Conference Call for May 6, 2022
Apr 28, 2022: T2 Biosystems Announces Formation and Members of Scientific Advisory Board